An upregulation of GLIS2 has been associated to NASH progression, and downregulation of DNASE1L3 is found in HCC and correlates to poor prognosis [15,16]. The gene discussed is DNASE1L3; the disease is metabolic dysfunction-associated steatohepatitis.